Target intelligence / Profile preview

Hemagglutinin Protein (Influenza Virus) (HA)

Target
HA
Molecular classification
Glycoprotein, Viral protein, Class I fusion protein
01

Overview

Hemagglutinin (HA) is a critical glycoprotein on the surface of influenza viruses, essential for viral infectivity. It mediates receptor binding to sialic acid-containing receptors on host cells and facilitates membrane fusion, enabling viral entry. As a major surface protein, it is a primary target of neutralizing antibodies and a key component of influenza vaccines. HA exhibits significant diversity and rapid evolution, necessitating constant monitoring and adaptation of vaccine strategies.

Other names
HA proteinInfluenza hemagglutininHemagglutinin-esterase fusion protein (HEF) - for Influenza C and D viruses
02

Mechanism of action

Neutralizing antibodies block receptor binding or prevent conformational change required for membrane fusion.

03

Biological functions

Receptor bindingMembrane fusionViral entryErythrocyte agglutination
04

Disease associations

InfectionInfluenzaViral pathogenesis
05

Safety considerations

Antigenic driftAntigenic shiftEvasion of neutralizing antibodiesNeed for regular vaccine updates

Beyond the preview

Go deeper on Hemagglutinin Protein (Influenza Virus) (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin Protein (Influenza Virus) (HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call